130 related articles for article (PubMed ID: 28850528)
1. Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial.
Peloso PM; Moore RA; Chen WJ; Lin HY; Gates DF; Straus WL; Popmihajlov Z
Scand J Pain; 2016 Oct; 13():175-181. PubMed ID: 28850528
[TBL] [Abstract][Full Text] [Related]
2. Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly.
Huang WN; Tso TK
Bosn J Basic Med Sci; 2018 Feb; 18(1):87-94. PubMed ID: 28954205
[TBL] [Abstract][Full Text] [Related]
3. Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial.
Lin HY; Cheng TT; Wang JH; Lee CS; Chen MH; Lei V; Lac C; Gammaitoni AR; Smugar SS; Chen WJ
Int J Rheum Dis; 2010 May; 13(2):144-50. PubMed ID: 20536599
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM
Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
[TBL] [Abstract][Full Text] [Related]
5. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.
Moore RA; Moore OA; Derry S; Peloso PM; Gammaitoni AR; Wang H
Ann Rheum Dis; 2010 Feb; 69(2):374-9. PubMed ID: 19364730
[TBL] [Abstract][Full Text] [Related]
6. Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo.
Bingham CO; Smugar SS; Wang H; Peloso PM; Gammaitoni A
Pain Med; 2011 Mar; 12(3):352-61. PubMed ID: 21332932
[TBL] [Abstract][Full Text] [Related]
7. Fourteen days of etoricoxib 60 mg improves pain, hyperalgesia and physical function in individuals with knee osteoarthritis: a randomized controlled trial.
Moss P; Benson HAE; Will R; Wright A
Osteoarthritis Cartilage; 2017 Nov; 25(11):1781-1791. PubMed ID: 28778815
[TBL] [Abstract][Full Text] [Related]
8. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
Yoo MC; Yoo WH; Kang SB; Park YW; Kim SS; Moon KH; Song YW; Min BW; Cho YJ; Moon SH; Bin SI; Baek HJ; Shim SC; Lee SW; Yoo DH; Mehta A; Skuban A; Cukrow DM; Vandormael K; Yan L
Curr Med Res Opin; 2014 Dec; 30(12):2399-408. PubMed ID: 25133963
[TBL] [Abstract][Full Text] [Related]
9. A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis.
Puopolo A; Boice JA; Fidelholtz JL; Littlejohn TW; Miranda P; Berrocal A; Ko A; Cichanowitz N; Reicin AS
Osteoarthritis Cartilage; 2007 Dec; 15(12):1348-56. PubMed ID: 17631392
[TBL] [Abstract][Full Text] [Related]
10. Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis.
Bingham CO; Bird SR; Smugar SS; Xu X; Tershakovec AM
Osteoarthritis Cartilage; 2008 Nov; 16(11):1289-93. PubMed ID: 18514551
[TBL] [Abstract][Full Text] [Related]
11. Relationship Between Pain Reduction and Improvement in Health-Related Quality of Life in Patients with Knee Pain Due to Osteoarthritis Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study.
Enomoto H; Fujikoshi S; Ogawa K; Tsuji T; Tanaka S
J Pain Res; 2020; 13():181-191. PubMed ID: 32021407
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a central mode of action for etoricoxib (COX-2 inhibitor) in patients with painful knee osteoarthritis.
Arendt-Nielsen L; Egsgaard LL; Petersen KK
Pain; 2016 Aug; 157(8):1634-1644. PubMed ID: 27007068
[TBL] [Abstract][Full Text] [Related]
13. Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores.
Moore RA; Moore OA; Derry S; McQuay HJ
Arthritis Res Ther; 2008; 10(2):R39. PubMed ID: 18384679
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of quality of life following treatment with etoricoxib in patients with arthritis or low-back pain: an open label, uncontrolled pilot study in Mexico.
Ramos-Remus CR; Hunsche E; Mavros P; Querol J; Suarez R
Curr Med Res Opin; 2004 May; 20(5):691-8. PubMed ID: 15140335
[TBL] [Abstract][Full Text] [Related]
15. Response to duloxetine in patients with knee pain due to osteoarthritis: an exploratory post hoc analysis of a Japanese Phase III randomized study.
Itoh N; Tsuji T; Ishida M; Ochiai T; Konno S; Uchio Y
J Pain Res; 2018; 11():2603-2616. PubMed ID: 30464579
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of single-domain versus multiple-domain outcome measures to identify responders in chronic low-back pain: pooled analysis of 2 placebo-controlled trials of etoricoxib.
Jensen MP; Schnitzer TJ; Wang H; Smugar SS; Peloso PM; Gammaitoni A
Clin J Pain; 2012 Jan; 28(1):1-7. PubMed ID: 21705875
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis.
Zacher J; Feldman D; Gerli R; Scott D; Hou SM; Uebelhart D; Rodger IW; Ozturk ZE;
Curr Med Res Opin; 2003; 19(8):725-36. PubMed ID: 14687444
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial.
Wiesenhutter CW; Boice JA; Ko A; Sheldon EA; Murphy FT; Wittmer BA; Aversano ML; Reicin AS;
Mayo Clin Proc; 2005 Apr; 80(4):470-9. PubMed ID: 15819283
[TBL] [Abstract][Full Text] [Related]
20. Increasing comorbidity is associated with worsening physical function and pain after primary total knee arthroplasty.
Hilton ME; Gioe T; Noorbaloochi S; Singh JA
BMC Musculoskelet Disord; 2016 Oct; 17(1):421. PubMed ID: 27717340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
